Clinical trial
A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.
NCT00425438 · Hoffmann-La Roche, Industry · Terminated
Key facts
| NCT number | NCT00425438 |
|---|---|
| Title | A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis. |
| Official title | A Randomized, Open-label Study to Compare the Effect of CellCept Plus Corticosteroids, and Cyclophosphamide Plus Corticosteroids Followed by Azathioprine, on Remission Rate in Patients With Lupus Nephritis |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lupus Nephritis |
| Intervention type | Drug |
| Interventions | Mycophenolate Mofetil, Corticosteroids, Azathioprine, Cyclophosphamide |
| Enrollment | 52 |
| Start date | Mar 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Jan 23, 2007 |
| Last update posted | Sep 25, 2014 |
| Countries | China |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: